Artificiality

SingularityNET and OriginTrail: Advancing Decentralized Knowledge Graphs

Retrieved on: 
torsdag, maj 30, 2024
SingularityNET, OriginTrail, Partnership, RWA, Internet, Organization, Blockchain, Hyperon, Verification, Privacy, Education, Artificiality, Artificial general intelligence, Ecosystem, Fourth Industrial Revolution, Bias, Forecasting, Hallucination, AI, Growth, Trace, DKG, Social media, Data analysis, AGI, Cryptocurrency

This partnership signifies that two prominent players in the AI industry have come together to support a decentralized ecosystem where AI agents and infrastructure partners collaborate within the decentralized knowledge graph (DKG) landscape.

Key Points: 
  • This partnership signifies that two prominent players in the AI industry have come together to support a decentralized ecosystem where AI agents and infrastructure partners collaborate within the decentralized knowledge graph (DKG) landscape.
  • This effort is aimed at enhancing the functionality and responsiveness of the decentralized knowledge graph within the OriginTrail network.
  • SingularityNET will then provide users access to its decentralized platform, where specialized AI models and Large Language Models (LLMs) can be purchased and used for data analysis.
  • The company will also develop AI models that can be trained directly on the Decentralized Knowledge Graph.

Asia-Pacific Artificial Intelligence/Machine Learning Medical Device Market Analysis and Forecast, 2022-2024 & 2032 Featuring Major Players - Canon, Ever Fortune.AI, AIRS Medical, and Annalise-AI - ResearchAndMarkets.com

Retrieved on: 
onsdag, maj 29, 2024
Medical Devices, Health, Technology, Health Technology, Artificial Intelligence, Partnership, Artificiality, Prevalence, Conditional sentence, Ecosystem, Artificial intelligence, Radiology, Ageing, AI, Growth, Research, Machine learning, Cardiology, Medical device

The "Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device Market: Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device Market: Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.
  • The Asia-Pacific (APAC) Artificial Intelligence and Machine Learning (AI/ML) medical device market is witnessing a significant surge in growth and innovation.
  • Competitive Strategy: The APAC artificial intelligence/machine learning medical device market is highly fragmented, including established companies and startups.
  • Key players in the APAC artificial intelligence/machine learning medical device market analyzed and profiled in the study involve established and emerging players that offer different AI-enabled medical devices.

Cloud Infrastructure Service Market Expected to Reach $282 Billion By 2033

Retrieved on: 
torsdag, maj 23, 2024
Cloud, News, PLTR, SNOW, Artificiality, A.I, Architecture, LLM, PDT, PALM, Intelligence, Trade winds, Element, Marketplace, Digital, Internet, Communication, OS, Software, Enterprise, CPU, Entrepreneurship, Cloud computing, PIN, USD, Tag cloud, SQL, SoundHound, Research, GAAP, Adjustment, Moe, OTCQB, Memory, EDT, Google Cloud, Artificial intelligence, AI, Growth, Acquisition, Medical device

A report from MarketResearch.Biz said that the cloud infrastructure service market was valued at USD 131.9 billion in 2023.

Key Points: 
  • A report from MarketResearch.Biz said that the cloud infrastructure service market was valued at USD 131.9 billion in 2023.
  • It is expected to reach USD $282.1 billion by 2033, with a CAGR of 8.11% during the forecast period from 2024 to 2033.
  • The report added: “The surge in demand for new cloud-based advanced technologies and the rise in data quantities are some of the main driving factors for the cloud infrastructure service market.” Cloud infrastructure plays an important role in cloud computing.
  • The virtualized resources are then developed by a cloud service provider in the case of a private cloud and made accessible to users all over the internet.

4th Annual Psychedelic Therapeutics and Drug Development Conference Scheduled for May 23-24 in Boston, MA

Retrieved on: 
torsdag, maj 16, 2024
Commercialization, Headache, Psychedelic drug, Drug development, Artificiality, University, Depression, Government, Anxiety, Opioid use disorder, PTSD, Therapy, Conference, Monitoring, MD, Hebrew University of Jerusalem, Framework, Emerging, Stuart Street, Dunedin, University of Alabama, Mental health, Intellectual property, Science, Brain, Emeritus, Pain, Personalized medicine, ADHD

The event will be hosted in the historic downtown center at the iconic Revere Hotel Boston Common, 200 Stuart Street, Boston, MA 02116.

Key Points: 
  • The event will be hosted in the historic downtown center at the iconic Revere Hotel Boston Common, 200 Stuart Street, Boston, MA 02116.
  • The conference has focus on research and development of psychedelics for various health conditions with considerable unmet need including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.
  • This distinctive event is curated to optimize business efficacy and impart invaluable practical guidance for collaborative partnerships among disparate disciplines with common objectives.
  • Attendees have the unique opportunity to delve into developments at the cutting-edge of psychedelic therapeutics while select researchers present their studies during highly innovative scientific poster sessions.

KalVista Pharmaceuticals Announces Ten Abstracts Accepted for Presentation at the European Academy of Allergy and Clinical Immunology Congress 2024

Retrieved on: 
fredag, maj 24, 2024
Biotechnology, Pharmaceutical, Health, Clinical Trials, Doctor of Philosophy, KALV, HAE, Artificiality, Hereditary angioedema, Congress, Data science, Artificial intelligence, Delays, Abstract, EAACI, Q&A, Master of Science, Medical device

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the acceptance of multiple abstracts and a symposium at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024 taking place in Valencia, Spain from May 31-June 3.

Key Points: 
  • KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced the acceptance of multiple abstracts and a symposium at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024 taking place in Valencia, Spain from May 31-June 3.
  • Results shared as a Late Oral Abstract Session on Clinical Trials on Friday, May 31, 2024, from 4:45-6:15 p.m. CEST in the Artificial intelligence and Data science Hub.
  • Symposium takes place on Saturday, June 1, 2024 from 6:45-7:45 p.m. CEST in the Alicante Room.
  • Results shared as a poster/ePoster presentation and Q&A on Sunday, June 2, 2024, from 12:00-1:00 p.m. CEST on Level 3 of the Central Forum in the Poster Zone

DentalMonitoring Sets New Standard In Orthodontic Remote Monitoring With De Novo Approval By the U.S. Food and Drug Administration (FDA).

Retrieved on: 
måndag, maj 20, 2024
Apps, Applications, Technology, Medical Devices, FDA, Dental, Health Technology, Health, General Health, Artificial Intelligence, Orthodontics, Patient, Dentistry, Medical device, Food, Algorithm, Artificiality, Diagnosis, Software, Artificial intelligence, Dental care, Smartphone, Caregiver, De novo, Research, Deep learning, Communication, Classification, Multimedia, STL

DentalMonitoring®, the leader in AI-powered remote monitoring for orthodontic treatment, has received De Novo approval from the U.S. Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in optimizing clinical care.

Key Points: 
  • DentalMonitoring®, the leader in AI-powered remote monitoring for orthodontic treatment, has received De Novo approval from the U.S. Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in optimizing clinical care.
  • View the full release here: https://www.businesswire.com/news/home/20240520240852/en/
    DentalMonitoring Sets New Standard in Orthodontic Remote Monitoring with De Novo Approval by the U.S. Food and Drug Administration (FDA) (Graphic: Business Wire)
    DentalMonitoring is a medical device software using image processing algorithms to analyze pictures of the oral cavity (hereinafter Scans).
  • DentalMonitoring is indicated for use for patients over the age of 6 and reports results solely on permanent teeth.
  • The product is designed to assist healthcare professionals in remotely monitoring dental treatments, orthodontic treatments, oral health, and treatment progress.

IHI Lucian Leape Institute Releases Artificial Intelligence (AI) Recommendations for Patient Safety and Health System Leaders

Retrieved on: 
onsdag, maj 15, 2024
Research, General Health, Data Management, Technology, Artificial Intelligence, Health Technology, Health Insurance, Clinical Trials, Science, Other Technology, Other Science, Health, Patient, Patient safety, LLI, Documentation, Artificiality, Challenge, Artificial intelligence, Safety, Depersonalization, MD, AI, IHI, Medical device

The IHI Lucian Leape Institute (LLI), a think tank within the Institute for Healthcare Improvement (IHI) that provides strategic vision for improving patient and workforce safety, today released, “ Patient Safety and Artificial Intelligence: Opportunities and Challenges for Care Delivery .” The comprehensive report, with insights from nearly 30 leading experts, includes a detailed analysis of the safety benefits, risks, and recommendations for generative artificial intelligence (genAI) applications.

Key Points: 
  • The IHI Lucian Leape Institute (LLI), a think tank within the Institute for Healthcare Improvement (IHI) that provides strategic vision for improving patient and workforce safety, today released, “ Patient Safety and Artificial Intelligence: Opportunities and Challenges for Care Delivery .” The comprehensive report, with insights from nearly 30 leading experts, includes a detailed analysis of the safety benefits, risks, and recommendations for generative artificial intelligence (genAI) applications.
  • The report includes detailed use cases about these applications, as well as strategies to mitigate the risks of genAI to patients and patient and workforce safety, and guardrails to consider.
  • It builds on the learnings from an IHI rapid-cycle innovation project conducted last year about genAI and how it is impacting the safety and quality of care.
  • “This report is a much-needed deep dive into the implications of AI on the safety and quality of care, as well as how AI is impacting health care professionals responsible for delivering that care,” said Kedar Mate, MD, President and CEO of IHI, and President of the IHI Lucian Leape Institute.

Capillary Technologies Tops SPARK Matrix™ as Loyalty Technology Leader

Retrieved on: 
tisdag, maj 14, 2024
Knowledge, Quotient, Customer data platform, Intelligence, Matrix, SPARK, Capillary Technologies, Artificiality, CLS, Quadrant, CDP, Retail

DALLAS, May 14, 2024 /PRNewswire/ -- Quadrant Knowledge Solutions named Capillary Technologies as a 2024 technology SPARK Leader in their latest SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report.

Key Points: 
  • With its comprehensive technology platform, Capillary Technologies receives the highest ratings across the parameters of technology excellence and strong ratings for customer impact.
  • DALLAS, May 14, 2024 /PRNewswire/ -- Quadrant Knowledge Solutions named Capillary Technologies as a 2024 technology SPARK Leader in their latest SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report.
  • Aneesh Reddy, Founder & CEO of Capillary Technologies said, "We are honored to lead the way in the SPARK Matrix for Customer Loyalty Solutions.
  • For additional details on Capillary Technologies and to access the full SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report, please visit Capillary Technologies' website .

Capillary Technologies Tops SPARK Matrix™ as Loyalty Technology Leader

Retrieved on: 
tisdag, maj 14, 2024
Knowledge, Quotient, Customer data platform, Intelligence, Matrix, SPARK, Capillary Technologies, Artificiality, CLS, Quadrant, CDP, Retail

DALLAS, May 14, 2024 /PRNewswire/ -- Quadrant Knowledge Solutions named Capillary Technologies as a 2024 technology SPARK Leader in their latest SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report.

Key Points: 
  • With its comprehensive technology platform, Capillary Technologies receives the highest ratings across the parameters of technology excellence and strong ratings for customer impact.
  • DALLAS, May 14, 2024 /PRNewswire/ -- Quadrant Knowledge Solutions named Capillary Technologies as a 2024 technology SPARK Leader in their latest SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report.
  • Aneesh Reddy, Founder & CEO of Capillary Technologies said, "We are honored to lead the way in the SPARK Matrix for Customer Loyalty Solutions.
  • For additional details on Capillary Technologies and to access the full SPARK Matrix™: Customer Loyalty Solutions, Q2 2024 report, please visit Capillary Technologies' website .

Ocean Power Technologies Successfully Demonstrates Advanced AI Solutions in the North Atlantic

Retrieved on: 
måndag, maj 6, 2024
Intelligence, Ocean Power Technologies, Artificiality, Algorithm, PowerBuoy, OPT, Artificial intelligence, Renewable energy

Further demonstrations for additional potential customers, including overseas prime contractors, are already scheduled to occur over the next few weeks.

Key Points: 
  • Further demonstrations for additional potential customers, including overseas prime contractors, are already scheduled to occur over the next few weeks.
  • Built with survivability and cybersecurity in mind, OPT can securely connect into this solution from anywhere in the world.
  • In addition to generating actionable intelligence, the data can also be used as a feed into Large Language Models or other Advanced AI systems.
  • For additional information about OPT and its services, please visit our website Ocean Power Technologies .